The Asia-Pacific OTC drug market is anticipated to grow at a CAGR of 7.9% during the forecast period (2019-2025). The market growth is attributed to the increasing shift of consumers towards self-medication, product innovation coupled with the focus of pharmaceutical companies to bring new products to the market. Further, the increasing healthcare expenditure, unhealthy dietary habits, growing population base in countries such as India and China further gives a boost to the growth of the Asia-Pacific OTC drug market.

The Asia-Pacific OTC drugs market is segmented based on product type and distribution channels. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit a considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health.

Based on the distribution channel, the market is bifurcated into retail & supermarkets, and online platform. The online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration. Further, the report covers the country-level analysis of China, Japan, India, and the Rest of Asia-Pacific. India is an emerging market in the OTC drugs landscape. Some of the common OTC drugs available in India include Aspirin, Ibuprofen, naproxin, paracetamol, and others.

Moreover, the study of the report covers the analysis of various players operating in the market. The Asia-Pacific OTC drug market is competitive in nature with the presence of a large number of well-established players in the region. Some of the key players covered in the report include Cipla Ltd., Novartis International AG, Johnson & Johsnon Services Inc. Piramal Group, Dabur India Ltd., Teva Pharmaceuticals Industries. Ltd., and Takeda Pharmaceuticals Co. Ltd. The players working in the generic medicine industry are making efforts to increase their market share by bringing new OTC drugs into the market.

Research Methodology

The market study of the Asia-Pacific OTC drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for the drug manufacturers, pharmaceutical excipient manufacturers, API manufacturers, industry associates & experts, pharmaceutical companies, pharmacies, government organizations, regulatory bodies, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Asia-Pacific OTC Drugs Market Research and Analysis by Product Type
2. Asia-Pacific OTC Drugs Market Research and Analysis by Distribution Channel

The Report Covers

• Comprehensive research methodology of the Asia-Pacific OTC drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific OTC drugs market.
• Insights about market determinants which are stimulating the Asia-Pacific OTC drugs market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.